Core Viewpoint - Sino Medical (688108.SH) reported its semi-annual results for 2025, highlighting a total institutional ownership of 107 million shares, representing 25.76% of the company's total equity, with a slight decline in institutional holding compared to the previous quarter [1] Institutional Investors - As of August 21, 2025, seven institutional investors disclosed their holdings in Sino Medical, with a combined shareholding of 107 million shares, accounting for 25.76% of the total equity [1] - The institutional investors include Tianjin Weixin Yangguang Enterprise Management Consulting Co., Ltd., Tianjin Yangguang Guoye Enterprise Management Partnership (Limited Partnership), Tianjin Yangguang Deye Enterprise Management Partnership (Limited Partnership), Tianjin Yangguang Yongye Enterprise Management Partnership (Limited Partnership), Beijing Shidai Fuxing Investment Management Co., Ltd. - Shidai Fuxing Taiping No. 1 Private Securities Investment Fund, Beijing Heju Private Fund Management Co., Ltd. - Heju Shiran No. 1 Private Securities Investment Fund, and CICC CSI 500 Index Enhanced A [1] - Compared to the previous quarter, the total institutional holding ratio decreased by 0.32 percentage points [1] Public Funds - During this period, one new public fund was disclosed, namely CICC CSI 500 Index Enhanced A [1] - One public fund, Xinao Small and Medium Cap Mixed A, was not disclosed in this quarter compared to the previous one [1]